Cas:17257-99-7 5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one manufacturer & supplier

Chemical Name:5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one

CAS.NO:17257-99-7

Synonyms:5-Brom-7,8-dihydro-pyrazino<2,3-d>pyridazin-8-on;8-Bromopyrazino[2,3-d]pyridazin-5(6H)-one;8-bromo-6H-pyrazino[2,3-d]pyridazin-5-one

Molecular Formula:C₆H₃BrN₄O

Molecular Weight:227.01800

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:2.253g/cm3

Index of Refraction:1.869

PSA:71.53000

Exact Mass:225.94900

LogP:0.47560

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Brom-7,8-dihydro-pyrazino&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-bromo-6H-pyrazino[2,3-d]pyridazin-5-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-d&gt Use and application,pyridazin-8-on technical grade,usp/ep/jp grade.

Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production. 5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one manufacturer The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. 5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one supplier Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one vendor Chung also said South Korean citizens who had visited the province in the past 14 days should voluntarily quarantine themselves at home for two weeks after they arrive back into the country. 5-bromo-7H-pyrazino[2,3-d]pyridazin-8-one factory Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.